Socid Friendly Socid Friendly
Risultati di ricerca
Mostra tutti i risultati
  • Iscriviti
    Registrati
    Iscriviti
    Cerca
    Night Mode

Cerca

Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie

  • Notizie
  • EXPLORE
  • Pagine
  • Gruppi
  • Events
  • Blogs
  • Marketplace
  • Offers
  • Jobs
  • Forums
  • Giochi
  • Developers
  • Articoli
  • Articles
  • Utenti
  • Pagine
  • Gruppi
  • Events
  • Yashodhan Alandkar ha aggiunto un file Health
    2026-04-30 11:17:07
    Precision Oncology Drug Portfolio market Forecast: Trends, Demand & Revenue Analysis
    "Precision Oncology Drug Portfolio Market Summary: According to the latest report published by Data Bridge Market Research, the Precision Oncology Drug Portfolio Market The global precision oncology drug portfolio market size was valued at USD 18.76 billion in 2025 and is expected to reach USD 45.46 billion by 2033, at a CAGR of 11.70% during the...
    0 Commenti 0 condivisioni 443 Views
    Effettua l'accesso per mettere mi piace, condividere e commentare!
  • Deepak Patle ha aggiunto un file Altre informazioni
    2026-03-12 11:12:24
    Clinical Oncology Next Generation Sequencing Market Trends, Precision Oncology Growth, and Forecast 2033
    Clinical Oncology Next Generation Sequencing Industry Insights: Straits Research recently introduced the latest update on the Clinical Oncology Next Generation Sequencing Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous...
    0 Commenti 0 condivisioni 1772 Views
    Effettua l'accesso per mettere mi piace, condividere e commentare!
  • Subhayan Mayra ha aggiunto un file Altre informazioni
    2026-04-22 10:24:52
    Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034
    According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...
    0 Commenti 0 condivisioni 1445 Views
    Effettua l'accesso per mettere mi piace, condividere e commentare!
  • Subhayan Mayra ha aggiunto un file Altre informazioni
    2026-04-18 10:04:55
    Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034
    According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...
    0 Commenti 0 condivisioni 1378 Views
    Effettua l'accesso per mettere mi piace, condividere e commentare!
  • Subhayan Mayra ha aggiunto un file Altre informazioni
    2026-04-20 11:20:27
    Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034
    According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...
    0 Commenti 0 condivisioni 1454 Views
    Effettua l'accesso per mettere mi piace, condividere e commentare!
  • Subhayan Mayra ha aggiunto un file Altre informazioni
    2026-04-13 12:28:25
    Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034
    According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...
    0 Commenti 0 condivisioni 1881 Views
    Effettua l'accesso per mettere mi piace, condividere e commentare!
© 2026 Socid Friendly Italiano
English Indonesia Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Brand Game Online Termini e Condizioni Privacy Contattaci Elenco